Home › Funds › Guggenheim › S&P Smallcap 600 Pure Growth Fund
Fund family: Guggenheim · Filed by RYDEX SERIES FUNDS (CIK 899148) · SEC series S000003768
Share classes and tickers: RYSGX (C000010446), RYWAX (C000010445), RYWCX (C000010447)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,083 with, 6 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Guggenheim’s manager page (148,731 ballot items across 82 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Guggenheim | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 89.1% | 1,072 | 91.0% | 135,765 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 5.8% | 1,981 |
Each ballot item this fund voted is set against the votes of the other Guggenheim funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Guggenheim funds on all 1,007 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 98.7% of this fund’s 1,089 such votes could be given a sector; the other 14 (1.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 249 | 3 | 1.2% |
| Consumer Discretionary | 245 | 2 | 0.8% |
| Industrials | 167 | 0 | 0.0% |
| Finance | 135 | 0 | 0.0% |
| Technology | 117 | 1 | 0.9% |
| Real Estate | 90 | 0 | 0.0% |
| Utilities | 25 | 0 | 0.0% |
| Consumer Staples | 17 | 0 | 0.0% |
| Telecommunications | 16 | 0 | 0.0% |
| Miscellaneous | 11 | 0 | 0.0% |
| Energy | 3 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 782 | 3 |
| Say-on-Pay | 137 | 0 |
| Audit-related | 123 | 0 |
| Compensation | 42 | 0 |
| Corporate Governance | 12 | 3 |
| Capital Structure | 5 | 0 |
| Shareholder Rights and Defenses | 2 | 0 |
| Extraordinary Transactions | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Acadian Asset Management Inc. | June 11, 2026 | $1M | 8 | 0 |
| Clear Secure, Inc. | June 10, 2026 | $1M | 13 | 0 |
| TG Therapeutics, Inc. | June 11, 2026 | $901,547 | 8 | 0 |
| ACM Research, Inc. | June 10, 2026 | $854,348 | 5 | 0 |
| DXP Enterprises, Inc. | June 12, 2026 | $807,698 | 8 | 0 |
| Ligand Pharmaceuticals Incorporated | June 5, 2026 | $761,516 | 11 | 0 |
| Sphere Entertainment Co. | June 10, 2026 | $732,126 | 7 | 0 |
| PTC Therapeutics, Inc. | June 2, 2026 | $685,425 | 6 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 9, 2026 | Etsy, Inc. | Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposal | Against | For |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
These funds reported the same votes as S&P Smallcap 600 Pure Growth Fund in the latest season, so they share this page:
1,104 ballot items at 128 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, S&P Smallcap 600 Pure Growth Fund (RYSGX) voted at 128 shareholder meetings of 128 companies, on 1,104 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 6 times. Its most frequent area of disagreement was director elections (3 of its votes against management). It voted on 6 shareholder proposals. It voted FOR the board's own proposals less often than Guggenheim's funds as a whole (89.1% against 91.0%). It voted the same way as most Guggenheim funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Guggenheim’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.